Details of the Drug Therapeutic Target (DTT)

General Information of Drug Therapeutic Target (DTT) (ID: TT8G3Z7)

DTT Name Serotoninnorepinephrinedopamine reuptake (SNDR)
Gene Name SNDR
DTT Type
Successful target
 [1]
UniProt ID
NOUNIPROTAC
TTD ID
T42748

Molecular Interaction Atlas (MIA) of This DTT

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DTT
1 Approved Drug(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
Dasotraline DMLDQFV Attention deficit hyperactivity disorder 6A05.Z Approved [2]
------------------------------------------------------------------------------------
3 Clinical Trial Drug(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
OPC-64005 DMIK2AD Attention deficit hyperactivity disorder 6A05.Z Phase 2 [3]
RP5063 DMKUE8O Schizophrenia 6A20 Phase 2 [2]
Brilaroxazine DM90J3J Idiopathic pulmonary fibrosis CB03.4 Phase 1 [4]
------------------------------------------------------------------------------------

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 Clinical pipeline report, company report or official report of Otsuka Pharmaceutical.
4 Clinical pipeline report, company report or official report of Reviva Pharmaceuticals